NEWS

Write a catchy title...

January 01, 2020

What's this item about? What makes it interesting? Write a catchy description to grab your audience's attention...

Olaris finds a new home in the AstraZeneca Boston BioHub!

October 01, 2019

Olaris has been invited to the AstraZeneca Incubator Labs at the Boston BioHub! We can't wait to join their community in Waltham, MA starting October 1st. 

Olaris CEO, Dr. Liz O'Day, featured in Life Science Leaders magazine article

October 03, 2019

Check out Life Science Leader's article about Olaris CEO, Dr. Liz O'Day, and PanTher Therapeutics CEO, Dr. Laura Indolfi's experience with the MLSC MassNextGen program and how it helped them grow their network and business.

Olaris has completed our Series A Financing Round!

September 30, 2019

We are proud to announce Olaris has completed its Series A funding led by Innospark Ventures. Our team's talent, passion, commitment and moral compass will continue define us in the next phase of Olaris' journey.

Olaris is presenting at the San Antonio Breast Cancer Symposium!

September 25, 2019

Olaris has been studying trastuzumab drug response in metastatic breast cancer patients and we are very proud to share our findings with everyone at SABCS, one of the largest breast cancer conferences in the US!

"Give Me Inspiration! The Paradigm Shift": Olaris CEO, Dr. Liz O'Day, talks with Master of Churchill College

September 16, 2019

"Give Me Inspiration! The Paradigm Shift" is a series of conversations with the Master of Churchill College, Professor Dame Athene Donald, that focuses on women leaders and what motivates them to continue to break down barriers. Olaris CEO and Churchill College alum, Dr. Liz O'Day, has been invited to participate in New York City next week.

Olaris CEO to sit on EY Women Leading Innovation Breakfast panel

September 12, 2019

The EY Women Leading Innovation Breakfast is next week and Olaris CEO, Dr. Liz O’Day, is sitting on a panel with four other incredible women changing the game in the health science field. These women will discuss their experience in the industry as well as how to showcase more women at the forefront of innovation.

Olaris is participating in World CB&CDx!

September 05, 2019

Can’t wait for next weeks’ World CB&CDx Boston conference, the world’s top clinical biomarker and companion diagnostics conference! Olaris CEO, Dr. Liz O’Day, will be a featured speaker and Olaris CCO, Leslie Hoyt, will be moderating the panel discussion. 

Olaris CEO will serve as Co-Chair for the Global Future Council on Biotechnology at the World Econoic Forum

August 22, 2019

Dr. Liz O'Day will serve her second term as the Co-Chair on the Global Future Council on Biotechnology. The Council supports the increased development of biotechnology across the world, while addressing global inequalities relating to access and treatment.

Olaris is a winner in the Innostars Competition!

July 10, 2019

Olaris is a preliminary winner in the Innostars competition which works to introduce American technology companies to opportunities in the Chinese market. Olaris will debut their technology in China and compete in Innostars industry finals.

Scientific American "Top 10 Emerging Technologies of 2019"

July 01, 2019

The Top 10 Emerging Technologies of 2019 are out and scientists are looking at a unique class of proteins as new possible targets for cancer and Alzheimer's drugs. Check out Olaris CEO's perspective on the topic.

MASLI Day! Olaris CEO speaks on VC and entrepreur panel

June 27, 2019

The Massachusetts Life Sciences Innovation Day highlights just how interconnected technology, life sciences and entrepreneurship are in our world. Olaris CEO, Dr. Liz O'Day, will be speaking on a panel with other entrepreneurs to discuss how they use this intertwined relationship to help patients.  

Two amazing days at the Charite Entrepreneurship Summit!

June 17, 2019

Olaris CEO, Dr. Liz O'Day, had the opportunity this week to exchange stories and perspectives with scientists and entrepreneurs from across the world at the Charite Entrepreneurship Summit hosted by the Berlin Institute of Health.

Olaris featured on "The Long Run" podcast

June 13, 2019

Listen to Olaris CEO, Dr. Liz O'Day, share Olaris' mission and how it all started on Luke Timmerman's biotech podcast, The Long Run.

Olaris Work Featured on the Breast Cancer Podcast!

June 01, 2019

As a major patient advocacy group for breast cancer patients, breastcancer.org works to provide support and information to women with breast cancer. The Olaris team had the opportunity to speak on the Breast Cancer podcast, a great platform to share Olaris' mission and the unlimited potential of biomarkers!

Olaris presents groundbreaking data ASCO 2019!

May 28, 2019

The Olaris Team gives poster presentation at the ASCO Annual Meeting on biomarker to optimize CDK4/6 treatment for breast cancer patients.

Olaris CEO sits on panel, "The Evolving Role of Biomarkers and Diagnostics"

April 24, 2019

Olaris CEO, Dr. Liz O'Day, sits on a panel at the Cancer Advance Conference to discuss how biomarkers and diagnostics are changing how we treat cancer. 

Olaris CEO on Steering Committee for Cancer Advance 2019

April 24, 2019

Cancer Advance Boston's Steering Committee has been working very hard to put together a brilliant group of speakers to discuss breakthrough cancer therapies and, equally as important, making sure these incredible therapies get to patients in need.

Olaris CEO named one of Women and Wealth Magaines's "19 Women to Watch in 2019"

April 09, 2019

Olaris CEO, Dr. Liz O'Day, is honored and proud to be included in such an inspiring group of women. Congratulations to all the other awardees!

Check-out Massachusetts Life Science Center's newsletter featuring Olaris CEO

March 21, 2019

The MLSC newsletter, "Data Challenger: Liz O'Day", discusses the Mass NextGen program, which supports women-led early-stage life science companies with funding and mentorship opportunities. Olaris CEO and one of the first awardees of the program, Dr. Liz O'Day, explains how she grew Olaris with the help of Mass NextGen.

Olaris CEO speaks at PANIC

March 03, 2019

Olaris CEO, Dr. Liz O'Day, had the opportunity to speak at the Practical Application of NMR in Industry Conference this week. The conference was an amazing opportunity to learn more about the latest technologies in NMR and to share how Olaris uses NMR to identify critical BoRs (Biomarkers of Response).

Olaris joins Innospark Venture's portfolio!

February 27, 2019

We are thrilled to announce that Olaris has joined the Innospark Venture's portfolio! So happy to be working with a company that shares Olaris' belief in the power of AI and data driven decisions.

What If: Everyone Had Their Genome Sequenced at Birth? Olaris CEO speaks at World Economic Forum

January 08, 2019

That's only the beginning of the conversation. Olaris CEO, Dr. Liz O'Day, tackles this question and the many more that follow with other panelists at the World Economic Forum. Listen to the thought-provoking discussion here.

Olaris CEO discusses "Big Data and Biofluids" on Dubai Future Talks

December 13, 2018

Olaris CEO, Dr. Liz O'Day,  discusses how big data and biobanks can be used to better diagnose and treat patients. The Olaris team is endlessly passionate about this mission and it was a pleasure to be able to share it on the Dubai Future Talks.

Olaris is partnering with Rheostat!

December 10, 2018

Rheostat works to develop novel treatment for neurodegenerative diseases and the Olaris team hopes to help them do just that with our biomarker platform!

Paper: Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells

October 15, 2018

Cancer cells have altered bioenergetics, which contributes to their ability to proliferate, survive in unusual microenvironments, and invade other tissues. Changes in glucose metabolism can have pleomorphic effects on tumor cells. To investigate potential mechanisms responsible for the increased malignancy associated with altered glucose metabolism, we used Olaris technology  to identify glucose metabolites differentially produced in a highly malignant human triple-negative breast cancer (TNBC) cell line (BPLER) and a less malignant isogenic TNBC cell line (HMLER).

Advanced Diagnostics Are Top Emerging Tech of 2018!

September 14, 2018

Advanced diagnostics was recognized by Scientific American as one of the top emerging technologies for 2018! Honored to co-author this piece on how biomarkers are literally revolutionizing how we diagnose and treat disease! Co-authored by CEO/Founder Dr. Elizabeth O'Day

Olaris wins Mass NextGen Award!

July 23, 2018

In partnership with the Massachusetts Life Science Center, Takeda and King Street Properties Olaris received the inaugural Mass NextGen Award which provides women-led early-stage life science companies non-dilutive grant funding and access to a network of seasoned Executive Coaches. 

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

May 24, 2018

From genome editing to precision medicine learn the details of how these biotechnologies are poised to transform health

Featured Interview in Lab Manager Magazine: Promoting a Startup Mindset in Your Laboratory

March 12, 2018

The most successful startups are able to walk the fine line between being both focused and flexible

Paper published "The power of synthetic biology for bioproduction, remediation and pollution control

March 26, 2018

The UN's Sustainable Development Goals will inevitably require the application of molecular biology and biotechnology on a global scale

Olaris wins a spot at Harvard's LifeLab

March 01, 2018

Olaris joins Johnson & Johnson family

February 01, 2018

Olaris has been awarded the JLABs "Golden Ticket".  

Human Metabolism Meets Entrepreneurship- a new course taught by Olaris CEO

December 04, 2017

Olaris CEO talks Precision Medicine at Strategic Session with the Ministers of the UAE

November 12, 2017

Olaris CEO serves of World Economic Forum Global Future Council of Biotechnology

November 11, 2017

Olaris CEO attends Annual New Champions Meeting in Dalian China

June 25, 2017

Olaris CEO invited speaker & contributor to AAUW meeting "Solving the Equation"

April 04, 2017

Olaris CEO invited Speaker Quest's "NEXTGEN WOMEN LEADERS PROGRAM"

February 15, 2017

Olaris CEO lectures at the Broad on "new biotech"

January 17, 2017

Real Talk about Alternative Careers with Entrepreneur, Dr. Liz O'Day (Tufts Biomedical Business Club)

December 06, 2016

Olaris CEO featured in LabManager Cover Article

December 02, 2016

Olaris CEO participates in UAE Value-Based Healthcare Strategic Session at Global Future Council Meeting

November 14, 2016

Speaker at BioEntrepreneur Bootcamp with MassBio, SR One and Pepper Hamilton

October 18, 2016

MIT Biotech Group Lunch Seminar with Liz O’Day, CEO and Founder of Olaris Therapeutics

August 25, 2016

CEO of Olaris speaks at StartUp Leadership Conferencec on "Getting Funded in LifeSciences"

August 04, 2016

Dr. Elizabeth O'Day named an Inspirational Woman of 2016

February 25, 2016

"3 ways personalized medicine will affect you" article by Olaris CEO, Dr. Elizabeth O'Day for the World Economic Forum